MRI Interventions Congratulates Dr. Clark Chen On First Patient Dosing In Minnesota For Phase 2 Glioblastoma Trial
IRVINE, Calif., March 25, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company developing products designed for navigation, ablation, deep brain stimulation, biopsy, aspiration and gene therapy, today congratulates …